Pain and Headache in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

被引:0
|
作者
Diaz, Paulina [1 ]
Nealon, Nancy E. [1 ]
Kaunzner, Ulrike W. [1 ]
机构
[1] Weill Cornell Med, Dept Neurol, 1305 York Ave, New York, NY 10021 USA
关键词
Myelin oligodendrocyte glycoprotein; MOGAD; Headache; Optic neuritis; Pain; Neuropathy; MOG; AQUAPORIN-4; DISORDERS; FEATURES;
D O I
10.1007/s11916-024-01322-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of ReviewThe purpose of this review is to evaluate the current knowledge and recent findings on different pain and headache presentations associated with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) disease.Recent FindingsMOGAD is an inflammatory autoimmune disease affecting mostly the central nervous system, presenting with optic neuritis, transverse myelitis and other forms of inflammatory demyelination. Pain and headache in MOGAD have been recognized more recently and acute and chronic forms of pain can occur in both the adult and pediatric population. An important recent observation is that MOGAD can affect the peripheral nervous system, which can contribute to pain symptoms.SummaryAcute and chronic forms of pain have been described in MOGAD, including ocular pain, different types of headaches and neuropathies, involving the central and peripheral nervous system. Awareness of these types of pain in both the pediatric and adult population is crucial, to ensure timely diagnosis and treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease according to their epitopes
    Seok, Jin Myoung
    Jeon, Mi Young
    Chung, Yeon Hak
    Ju, Hyunjin
    Lee, Hye Lim
    Kwon, Soonwook
    Min, Ju-Hong
    Kang, Eun-Suk
    Kim, Byoung Joon
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [42] Current Ophthalmologic Management of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in Alberta
    Burton, J.
    Youn, S.
    Al-Ani, A.
    Costello, F.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 102 - 102
  • [43] Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges
    Abdullah Al-Ani
    John J. Chen
    Fiona Costello
    Journal of Neurology, 2023, 270 : 4132 - 4150
  • [44] Cognitive and academic outcomes in childrenwith myelin oligodendrocyte glycoprotein antibody-associated disease
    Mittelman, Audrey
    Pique, Julie
    Desportes, Vincent
    Deiva, Kumaran
    Poulat, Anne-Lise
    Marignier, Romain
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2025, 67 (04): : 529 - 536
  • [45] Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
    Wolf, Andrew B.
    Palace, Jacqueline
    Bennett, Jeffrey L.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2023, 25 (11) : 437 - 453
  • [46] Increased Intracranial Pressure in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
    Nguyen, Linda
    Miles, Darryl K.
    Harder, Lana
    Singh, Sumit
    Whittemore, Brett A.
    Greenberg, Benjamin M.
    Wang, Cynthia X.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (01):
  • [47] Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in a patient with lung adenocarcinoma
    Valcarcel, Sena
    Muniz, Isabel
    MEDICINA CLINICA, 2024, 163 (11):
  • [48] Chi-separation imaging in myelin oligodendrocyte glycoprotein antibody-associated disease
    Ko, Eunbuel
    Shin, Hyeong-Geol
    Jang, Jinhee
    Kim, Woojun
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 853 - 854
  • [49] Myelin oligodendrocyte glycoprotein antibody-associated disease in children: Are there MRI predictors of relapse?
    Singh, Sumit
    Ness, Jayne
    Marcus, Lydia
    JOURNAL OF NEURORADIOLOGY, 2023, 50 (04) : 382 - 387
  • [50] Criteria for myelin oligodendrocyte glycoprotein antibody-associated disease: Balancing underdiagnosis with overdiagnosis
    Li, Er-Chuang
    Lai, Qi-Lun
    Cai, Meng-Ting
    Fang, Wei
    Ding, Mei-Ping
    Zhang, Yin-Xi
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2023, 3 (04):